96 Unlocking the Potential of Simalikalactone D as an Anticancer Agent in Ethnically Diverse Breast Cancer Populations
OBJECTIVES/GOALS: This project focuses on investigating the potential of Simalikalactone D (SKD) as an anticancer agent, exploring the mechanisms underlying SKD’s induction of cell death, and assessing the impact of SKD on diverse breast cancer cell lines. Also, it Investigates the compound’s mechan...
Main Authors: | Annelis O. Sanchez-Alvarez, Pablo E. Vivas-Mejia, Claudia Ospina |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2024-04-01
|
Series: | Journal of Clinical and Translational Science |
Online Access: | https://www.cambridge.org/core/product/identifier/S2059866124000943/type/journal_article |
Similar Items
-
Chemistry and pharmacological diversity of quinoxaline motifs as anticancer agents
by: Ajani Olayinka O., et al.
Published: (2019-06-01) -
Cytobiological Alterations Induced by Celecoxib as an Anticancer Agent for Breast and Metastatic Breast Cancer
by: Maher Monir. Akl, et al.
Published: (2024-10-01) -
An anticancer agent
by: Othman, Fauziah, et al.
Published: (2009) -
Is Irisin Anticancer Agent?
by: Işıl Yıldırım
Published: (2018-12-01) -
Novel Arylsulfonylhydrazones as Breast Anticancer Agents Discovered by Quantitative Structure-Activity Relationships
by: Violina T. Angelova, et al.
Published: (2023-02-01)